Key result
Aeson, the Carmat Total Artificial Heart, has been approved by the FDA to begin enrollment in the United States following its 2020 CE marking.
Design
Editorial
Authors
Loading...
The Carmat Total Artificial Heart (Aeson) has received FDA approval to begin clinical enrollment in the United States.
The Carmat Total Artificial Heart (Aeson) has received FDA approval to begin clinical enrollment in the United States.
Jason J. Han (2021) studied this question. Aeson, the Carmat Total Artificial Heart, has been approved by the FDA to begin enrollment in the United States following its 2020 CE marking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: